ZG8_9544-E.jpg
November 14, 2024COURTESY OF ELEDON PHARMACEUTICALS Eledon Pharmaceuticals, Inc. (Eledon), is a biotechnology company. In an interview with The News-Letter, its CEO, Johns Hopkins School of Medicine Class of 1999 alum Dr. David-Alexandre C. Gros, discussed the latest updates regarding their tegoprubart treatment.